113 related articles for article (PubMed ID: 1867031)
21. Guinea pig complement potently measures vibriocidal activity of human antibodies in response to cholera vaccines.
Kim KW; Jeong S; Ahn KB; Yang JS; Yun CH; Han SH
J Microbiol; 2017 Dec; 55(12):973-978. PubMed ID: 29214494
[TBL] [Abstract][Full Text] [Related]
22. Antitoxic immunity to cholera in dogs immunized orally with cholera toxin.
Pierce NF; Cray WC; Engel PF
Infect Immun; 1980 Feb; 27(2):632-7. PubMed ID: 7380543
[TBL] [Abstract][Full Text] [Related]
23. Serological studies in cholera. 2. The vibriocidal antibody response of cholera patients determined by a microtechnique.
Benenson AS; Saad A; Mosley WH
Bull World Health Organ; 1968; 38(2):277-85. PubMed ID: 5302303
[TBL] [Abstract][Full Text] [Related]
24. Incomplete correlation of serum vibriocidal antibody titer with protection from Vibrio cholerae infection in urban Bangladesh.
Saha D; LaRocque RC; Khan AI; Harris JB; Begum YA; Akramuzzaman SM; Faruque AS; Ryan ET; Qadri F; Calderwood SB
J Infect Dis; 2004 Jun; 189(12):2318-22. PubMed ID: 15181581
[TBL] [Abstract][Full Text] [Related]
25. [Systemic immunity of experimental animals immunized with cholera vaccines].
Genova IuG; Bogatinov VT; Manakhilov RB; Kostova EF
Zh Mikrobiol Epidemiol Immunobiol; 1987 Nov; (11):41-4. PubMed ID: 3434048
[TBL] [Abstract][Full Text] [Related]
26. Type-specific action of vibriocidal antibody on Vibrio cholerae.
Pykett AH; Preston NW
J Hyg (Lond); 1975 Dec; 75(3):399-406. PubMed ID: 1059707
[TBL] [Abstract][Full Text] [Related]
27. Supplementation with zinc, but not vitamin A, improves seroconversion to vibriocidal antibody in children given an oral cholera vaccine.
Albert MJ; Qadri F; Wahed MA; Ahmed T; Rahman AS; Ahmed F; Bhuiyan NA; Zaman K; Baqui AH; Clemens JD; Black RE
J Infect Dis; 2003 Mar; 187(6):909-13. PubMed ID: 12660937
[TBL] [Abstract][Full Text] [Related]
28. Immunity of cholera in man: relative role of antibacterial versus antitoxic immunity.
Levine MM; Nalin DR; Craig JP; Hoover D; Bergquist EJ; Waterman D; Holley HP; Hornick RB; Pierce NP; Libonati JP
Trans R Soc Trop Med Hyg; 1979; 73(1):3-9. PubMed ID: 442179
[TBL] [Abstract][Full Text] [Related]
29. Kinetics of the vibriocidal antibody response to live oral cholera vaccines.
Wasserman SS; Losonsky GA; Noriega F; Tacket CO; Castañeda E; Levine MM
Vaccine; 1994 Aug; 12(11):1000-3. PubMed ID: 7975839
[TBL] [Abstract][Full Text] [Related]
30. Field trial of oral cholera vaccines in Bangladesh: serum vibriocidal and antitoxic antibodies as markers of the risk of cholera.
Clemens JD; van Loon F; Sack DA; Chakraborty J; Rao MR; Ahmed F; Harris JR; Khan MR; Yunus M; Huda S
J Infect Dis; 1991 Jun; 163(6):1235-42. PubMed ID: 2037789
[TBL] [Abstract][Full Text] [Related]
31. [Seroepidemiological survey of El Tor cholera in an endemic region of Algeria].
Bendib A; Nora M; Mahrouf H; Saib M; el Abassi K; Dodin A
Bull Soc Pathol Exot; 1994; 87(3):143-7. PubMed ID: 7827512
[TBL] [Abstract][Full Text] [Related]
32. Experimental studies on cholera immunization. 4. The antibody response to formalinized Vibrio cholerae and purified endotoxin with special reference to protective capacity.
Svennerholm AM
Int Arch Allergy Appl Immunol; 1975; 49(4):434-52. PubMed ID: 808500
[TBL] [Abstract][Full Text] [Related]
33. Vibriocidal antibody and antibodies to Vibrio cholerae lipopolysaccharide, cell-bound haemagglutinin and toxin in Thai population.
Chongsa-nguan M; Chaicumpa W; Kalambaheti T; Soejoedi H; Luxananil P; Swasdikosa S; Thanasiri P; Mayurasakorn S
Southeast Asian J Trop Med Public Health; 1986 Dec; 17(4):558-66. PubMed ID: 3576285
[TBL] [Abstract][Full Text] [Related]
34. Breast milk reduces the risk of illness in children of mothers with cholera: observations from an epidemic of cholera in Guinea-Bissau.
Qureshi K; Mølbak K; Sandström A; Kofoed PE; Rodrigues A; Dias F; Aaby P; Svennerholm AM
Pediatr Infect Dis J; 2006 Dec; 25(12):1163-6. PubMed ID: 17133163
[TBL] [Abstract][Full Text] [Related]
35. Cholera antibody response in immunized persons in a cholera free area. II. Vibriocidal antibodies.
Chirescu N; Năcescu N; Ciufecu C
Arch Roum Pathol Exp Microbiol; 1974 Jun; 33(2):149-53. PubMed ID: 4412422
[No Abstract] [Full Text] [Related]
36. Immunological response to Vibrio cholerae O1 infection and an oral cholera vaccine among Peruvians.
Sanchez JL; Hayashi KE; Kruger HF; Meza R; English CK; Vidal W; Svennerholm AM; Taylor DN
Trans R Soc Trop Med Hyg; 1995; 89(5):542-5. PubMed ID: 8560536
[TBL] [Abstract][Full Text] [Related]
37. [The development of biochip to detect anti-cholera antibodies in human blood serum].
Utkin DV; Osina NA; Spitsin AN; Kireev MN; Gromova OV; Zakharova TL; Naidenova EV; Kuklev VE
Klin Lab Diagn; 2015 Feb; 60(2):50-3. PubMed ID: 26027261
[TBL] [Abstract][Full Text] [Related]
38. A semi-automated vibriocidal assay for improved measurement of cholera vaccine-induced immune responses.
Yang JS; Kim HJ; Yun CH; Kang SS; Im J; Kim HS; Han SH
J Microbiol Methods; 2007 Nov; 71(2):141-6. PubMed ID: 17888533
[TBL] [Abstract][Full Text] [Related]
39. [GM1-dot-EIA for the detection of toxin-producing Vibrio cholerae strains].
Markina OV; Alekseeva LP; Telesmanich NR; Chemisova OS; Akulova MV; Markin NV
Klin Lab Diagn; 2011 May; (5):49-52. PubMed ID: 21786618
[TBL] [Abstract][Full Text] [Related]
40. IEM101, a naturally attenuated Vibrio cholerae strain as carrier for genetically detoxified derivatives of cholera toxin.
Fontana MR; Monaci E; Yanqing L; Guoming Q; Duan G; Rappuoli R; Pizza M
Vaccine; 2000 Aug; 19(1):75-85. PubMed ID: 10924789
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
